Physician profile
Bradley S Rust
NPI 1104890003
$1,735.80
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $27.29 · 2021: $175 · 2022: $514 · 2023: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.99 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $415.67 | 2021-2023 | Glassia |
| Insmed, INC. | $260.30 | 2019-2023 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.84 | 2019-2023 | Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $194.73 | 2021-2023 | Breztri, Fasenra, Farxiga |
| Philips North America LLC | $146.43 | 2019-2023 | |
| Mylan Specialty L.P. | $141.87 | 2019-2022 | |
| Glaxosmithkline, LLC. | $126.07 | 2020-2023 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $63.62 | 2019 | |
| Electromed, INC. | $38.72 | 2021-2022 | |
| Genentech USA, INC. | $31.34 | 2019 | |
| Baxter Healthcare | $26.07 | 2022 | |
| Genzyme Corporation | $24.07 | 2022 | |
| United Therapeutics Corporation | $17.80 | 2021 | |
| Advanced Respiratory, INC | $15.55 | 2021 | |
| Grifols USA, LLC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Rust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.